Stocks making the biggest moves midday: Nvidia, Moderna, IonQ, Airbnb, Firefly Aerospace & more

IonQ rose 17% after raising revenue guidance to $505M-$515M. Firefly Aerospace surged 30% on a $1.3B deal with AST SpaceMobile. Microchip Technology fell 14% due to weak guidance. Moderna gained 7% after beating earnings and raising sales outlook. Lam Research jumped 9% on a $25B buyback plan. Five9 dropped 17% after lowering EPS guidance and announcing an acquisition. Airbnb climbed 11% on strong earnings. JFrog soared 35% after raising full-year guidance.

Original reporting
Published Nov 6, 2026, 5:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 6:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks making the biggest moves midday: Nvidia, Moderna, IonQ, Airbnb, Firefly Aerospace & more — source image
Decision brief

The 30-second read

$IONQBullishMed
01

Why it matters

The article provides same-session catalysts with explicit guidance numbers for multiple companies, enabling traders to update near-term expectations and risk management immediately.

02

Market read

Actionable for traders because it reports same-session guidance and earnings catalysts with specific numeric ranges that can drive immediate repricing.

03

What to watch

For contract and buyback stories, traders may need follow-through on timing, backlog conversion, and how guidance translates into free cash flow, not just revenue/EPS.

Relevance 8/10Novelty 6/10Timing: midday trading catalysts reported in the same session

Background

This is a midday multi-stock movers roundup, where each named company’s move is attributed to a fresh guidance, earnings, buyback, acquisition, or contract headline.

Company-level read

Ticker impact

$IONQBullishHigh confidence
Context

IonQ shares rose 17% after the company lifted full-year revenue guidance to $505 million to $515 million.

Expected impact

Likely upward bias as traders reprice the raised full-year revenue range.

Evidence & confidence

The article attributes the midday surge directly to a specific guidance increase with a clear revenue range.

$MCHPBearishHigh confidence
Context

Microchip Technology tumbled 14% on largely disappointing current-quarter guidance with Q3 revenue $1.573 billion to $1.638 billion.

Expected impact

Likely downside pressure as traders adjust earnings expectations to the guided range.

Evidence & confidence

The article directly links the sharp drop to specific guidance that misses consensus.

$MRNABullishHigh confidence
Context

Moderna rallied 7% after smashing Q3 earnings estimates and raising full-year revenue growth guidance to 15% to 25%.

Expected impact

Likely upward bias as the market incorporates the higher full-year growth range.

Evidence & confidence

The article ties the move to both an earnings beat and an explicit guidance upgrade.

$LRCXBullishMedium confidence
Context

Lam Research surged nearly 9% after its board authorized a $25 billion stock buyback.

Expected impact

Likely positive drift as traders price in capital return and reduced share count risk.

Evidence & confidence

The buyback size is clear, but the article does not specify timing or execution pace.

$AXONBearishHigh confidence
Context

Axon Enterprise dropped 18% after Q3 EPS and revenue missed estimates and it issued weak Q4 guidance.

Expected impact

Likely downside bias as traders reprice the near-term revenue and earnings trajectory.

Evidence & confidence

The article directly attributes the large decline to the miss and guidance weakness.

$NETBullishHigh confidence
Context

Cloudflare shares climbed about 12% after its current-quarter guidance topped Street expectations with adjusted earnings of 43 cents.

Expected impact

Likely upward bias as the market incorporates the higher quarterly earnings and revenue range.

Evidence & confidence

The article provides explicit guidance numbers and states they beat consensus.

$IRENBullishMedium confidence
Context

Iren jumped 19% after fiscal first-quarter revenue rose to $228 million and projected annual recurring revenue was delayed to at least January 2027.

Expected impact

Likely mixed-to-positive trading as investors balance the beat with the delayed ARR timing.

Evidence & confidence

The article includes both a positive revenue print and a meaningful delay, making direction less certain.

$ABNBBullishHigh confidence
Context

Airbnb jumped 11% after Q3 EPS of $3.16 and revenue of $4.87 billion beat analyst consensus.

Expected impact

Likely continued strength as traders follow through on the beat and raised expectations.

Evidence & confidence

The article explicitly links the move to both EPS and revenue beats versus consensus.

Market effects

Semiconductor and AI-adjacent names show divergent tape behavior driven by guidance and capital return, reinforcing stock-specific selection over pure index beta.

Primarily US-listed single-name repricing; limited direct cross-region linkage beyond sector sentiment.

Space and quantum contract/guidance headlines can spill into global risk appetite for high-growth tech, but the article is mostly company-specific.

Counterpoint

Some moves may be exaggerated by intraday positioning, especially where the article highlights guidance ranges without detailing execution risk or margin impact.

Key entities

  • IonQ

    Quantum computing company that lifted full-year revenue guidance.

  • Firefly Aerospace

    Rocket engine and IP licensing agreement with AST SpaceMobile.

  • Microchip Technology

    Semiconductor manufacturer with disappointing current-quarter guidance.

  • Moderna

    Vaccine maker that beat Q3 and raised full-year revenue growth guidance.

  • Lam Research

    Semiconductor equipment maker that authorized a $25 billion stock buyback.

Related articles

$MRNAHighAI 8/10

Moderna, Inc. Q3 2026 Earnings Call Summary

Moderna reported 29% revenue growth and $200M net income in Q3 2026, driven by mNEXSPIKE adoption and cost reductions. The company raised its full-year revenue guidance to 15-25% and plans to submit a BLA for Intismeran in melanoma by year-end. It also secured $3B for oncology growth and paused a norovirus vaccine program. Management expressed confidence in upcoming clinical milestones and proprietary cancer therapy advantages.

$MSFTMed

Microsoft winds down Oracle AI cloud capacity agreement

Microsoft is ending its agreement with Oracle to rent AI computing capacity, as the older Nvidia chips no longer meet its needs. Oracle claims strong demand for its AI infrastructure, including older GPUs. Microsoft has over $80B in cloud commitments and is reviewing its supplier agreements. IREN, a Bitcoin miner, faces delays in its Microsoft deployment. Oracle and Microsoft have other AI cloud partnerships, including one with OpenAI.

$AXONHighAI 8/10

Axon Enterprise earnings analysis: questions answered and next catalysts

Axon Enterprise (AXON) shares fell 18.24% to $312.79, a 52-week low, after reporting Q3 FY2026 earnings below estimates. Revenue grew 28% YoY to $908.55M, but EPS missed at $1.72 vs. $1.91. Analysts note demand is intact, with software growth strong, but hardware margins and guidance cuts raise concerns. Next catalysts include Q4 earnings, Dedrone deals, and Taser hardware recovery.